ImmuCell Corp (NASDAQ:ICCC)
| 4.57 Delayed Data As of Dec 08 |  +0.11 / +2.47%Today’s Change | 4.26 Today|||52-Week Range 7.84 | -25.08% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 1.2M | 508.4K | -168.1K | -2.3M | |
| Depreciation | 529.3K | 802.4K | 904.4K | 1.5M | ||
| Total Other Cash Flow | 19.2K | 104.9K | 191.4K | -337.4K | ||
| Funds From Operations | 2.6M | 1.7M | 642.9K | -676.1K | ||
| Funds From/For Other Operating Expenses | -317.0K | 2.0M | -532.9K | -302.7K | ||
| Net Cash Flow - Operating Activities | 2.9M | -323.9K | 1.2M | -373.4K | ||
| Investing | Increase In Investments | -4.5M | -5.0M | -249.0K | 0.00 | |
| Decrease In Investments | 2.5M | 4.5M | 5.7M | 0.00 | ||
| Capital Expenditures | -2.7M | -3.6M | -17.8M | -2.0M | ||
| Fixed Asset Disposal | 66.2K | 30.9K | 45.0K | 250.0K | ||
| Net Assets From Acquisitions | 0.00 | -368.2K | -8.7K | -14.1K | ||
| Net Cash Flow Investing | -4.6M | -4.4M | -12.3M | -1.8M | ||
| Financing | Short Term Borrowings | -- | -- | -- | 500.0K | |
| Long Term Borrowings | 2.5M | -46.7K | 6.1M | 691.7K | ||
| Long Term Debt Reduction | -169.8K | -135.8K | -152.0K | -398.3K | ||
| Net Proceeds Stock Sale | 120.2K | 8.5M | 3.8M | 96.3K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 25.7K | 0.00 | 0.00 | 0.00 | ||
| Other Uses - Financing | -- | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 2.4M | 8.3M | 9.7M | 889.6K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 723.3K | 3.6M | -1.4M | -1.3M | ||
